Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - simvastatin - filmovertrukne tabletter - 80 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+12,5 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 80+12,5 mg

Europska Unija - danski - EMA (European Medicines Agency)

actavis group ptc ehf   - pioglitazonhydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapyin adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. as dual oral therapy in combination withmetformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin. a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination withmetformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy. pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance (see section 4. efter initiering af behandling med pioglitazon, patienter bør revurderes efter 3 til 6 måneder for at vurdere tilstrækkeligheden af respons på behandlingen (e. reduktion i hba1c). hos patienter, der undlader at vise et passende svar, pioglitazon bør seponeres. i lyset af potentielle risici med langvarig terapi, ordinerende læger bør bekræftes ved en efterfølgende rutinemæssige vurderinger, der har gavn af pioglitazon er fastholdt (se afsnit 4.

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - candesartancilexetil - tabletter - 16 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - candesartancilexetil - tabletter - 32 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - candesartancilexetil - tabletter - 8 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - candesartancilexetil, hydrochlorthiazid - tabletter - 16+12,5 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - isotretinoin - kapsler, bløde - 10 mg